3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
3
Completed
3
Withdrawn
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Lymphoid
3
Plasma cell
2
Other hematologic neoplasm
2
Conditions
Breast Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
3
Lymphoma
3
Leukemia
3
Hematologic Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Hematopoietic and Lymphoid System Neoplasm
1
Gastrointestinal Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Depression
1
Colonic Neoplasms
1
Chemotherapy Effect
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Anxiety Disorders
1
Interventions
Cyclophosphamide
27
fludarabine
18
Rituximab
17
obinutuzumab
11
venetoclax
9
Bendamustine Hydrochloride
9
Lenalidomide
8
zanubrutinib
6
Prednisone
6
Doxorubicin
6
Blood Specimen Collection
6
pembrolizumab
5
fludarabine phosphate
5
Biopsy
5
ibrutinib
4
glofitamab
4
Vincristine
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Exercise
4
loncastuximab tesirine
3
gamma-Globulins
3
axicabtagene ciloleucel
3
acalabrutinib
3
Temozolomide
3
Surveys and Questionnaires
3
Palliative Care
3
Mycophenolic Acid
3
Methotrexate
3
Mesna
3
Magnetic Resonance Spectroscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma
×
Palliative Care
×
Clear all
NCT05646576
2026-04-21
PEACE
Massachusetts General Hospital
Phase NA
Recruiting
90 enrolled
NCT07032103
2025-06-22
SMCLYM-IV
Samsung Medical Center
Recruiting
2,000 enrolled
NCT05190653
2024-07-31
PALS_CT
Alberta Health Services, Calgary
Phase NA
Recruiting
152 enrolled